VIM and Sepsis: Anti-vimentin antibody reduced the fibrin formation potential and increased fibrin clot porosity in plasma from the septic piglets. We have previously shown that extracellular vimentin can engage fibrinogen and modulate fibrin polymerization in patients with sepsis [8].